Full Circles Therapeutics develops targeted genomic integration technology for treating genetic diseases and cancer.
Its GATALYST platform delivers circular, single-stranded DNA for integration into genomic safe harbors in disease-relevant cell types. The company states that it discovers, develops, and manufactures genomic therapies.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The GATALYST platform delivers circular, single-stranded DNA for genomic safe-harbor integration in disease-relevant cell types, with no stated donor DNA sequence size limitations.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.Snapshot: September 15, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 11, 2026, September 15, 2026, September 18, 2026, September 19, 2026 and September 26, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.